Tissue fibrosis — Killer #1 in the western world: The basic research
The pathobiology underlying lung fibrosis and drug development is reviewed.
Jack Gauldie, a professor of pathology and molecular medicine, reviews the pathobiology underlying lung fibrosis and explains how these pathogenetic concepts are translated into drug development.
[Please complete our feedback form]
Demystifying Medicine, Education, Idiopathic pulmonary fibrosis (IPF), Pulmonary Research Registry (PURR)
Related News
News Listing
Fly on the Wall: Improving maternal health outcomes in Canada
Dept. ObGyn, Education, Feature, Fly on the wall
6 days ago